|Year : 2019 | Volume
| Issue : 4 | Page : 299-302
|Eruptive lichen planus, a marker of metabolic syndrome
Gopalan Geetharani, Sundararaj Sumithra, Sendurpandian Devaprabha, Rajagopalan Kothandaramasamy
Department of Dermatovenereology, Government Rajaji Hospital, Madurai Medical College, Madurai, Tamil Nadu, India
|Date of Web Publication||5-Jul-2019|
No. 1/A, Model House, L.I.G. Colony, K.K. Nagar, Madurai - 625 020, Tamil Nadu
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Chronic inflammatory diseases take an important place in dermatology and their effects range from mild itching to grave metabolic complications. In psoriasis, association with metabolic syndrome (MS) has been proved in many studies. Chronic inflammation is a trigger of MS, and in turn, the components of MS, namely obesity and dyslipidemia, promote a pro-inflammatory milieu. Thus, chronic inflammation causes MS and vice versa. Hence, the study focuses on association of MS with lichen planus (LP), another chronic inflammatory disease. Aim: The aim of this study is to find the association of MS with all variants of LP. Materials and Methods: An observational study for MS in all patients with LP who attended skin outpatient department (OPD) for 6 months from February 2016. International Diabetes Federation criteria 2005 were used. The confounding variables of MS such as smoking, alcohol, and physical activity were assessed for its significance in the association of LP with MS. Results: Out of 113 cases, 21 cases were found to be associated with MS. Among them, 8 cases (38.09%) were of eruptive LP, which showed significant association with MS when compared to other variants. MS cases were significantly high in females and in the age group of 41–50 (57.1%). Due to unequal distribution of smoking and alcohol habits, they were not taken into account for analysis. Physical activity had no significant association with MS in our study population. Waist circumference (WC) being the mandatory criterion in all variants associated with MS, dyslipidemia was the next frequently encountered criteria except in eruptive LP. High BP was less commonly noted criteria. Conclusion: Eruptive LP showed significant association with MS. Further studies with large sample size in each variant and control group are needed to confirm it which are the limitations in our study.
Keywords: Lichen planus, metabolic syndrome, obesity
|How to cite this article:|
Geetharani G, Sumithra S, Devaprabha S, Kothandaramasamy R. Eruptive lichen planus, a marker of metabolic syndrome. Indian J Dermatol 2019;64:299-302
|How to cite this URL:|
Geetharani G, Sumithra S, Devaprabha S, Kothandaramasamy R. Eruptive lichen planus, a marker of metabolic syndrome. Indian J Dermatol [serial online] 2019 [cited 2019 Jul 19];64:299-302. Available from: http://www.e-ijd.org/text.asp?2019/64/4/299/262181
| Introduction|| |
Lichen planus (LP) is a papulosquamous disorder involving skin and mucous membranes. Main pathogenesis is keratinocyte apoptosis by CD8 cell augmented by CD4 cell Th1 cytokines IL-2, 4, 6, 10, and TNF-α., These cytokines also play causal role in insulin resistance and obesity, components of metabolic syndrome (MS). Obesity causes adipocyte hypertrophy and on rupture releases pro-inflammatory cytokines TNF-α, IL-6, and TGF-β. Thus, there exists association of MS with inflammation. Baykal et al. showed association of MS with oral LP. The aim of our study is to find the association of MS with cutaneous variants of LP.
| Materials and Methods|| |
The study was conducted from February 2016 to July 2016. Newly diagnosed patients of LP with classical clinical features attending the OPD during this period were included. In case of diagnostic dilemma, biopsy was done to confirm the diagnosis.
LP patients of age group less than 10 years, patients on treatment for diabetes mellitus and hypertension, old cases of LP on treatment, and those who did not give consent were excluded.
International Diabetes Federation – 2005 criteria
International Diabetes Federation (IDF) criteria 2005 for diagnosis of metabolic syndrome (MS) were used in the study. Patients with waist circumference (WC) >90 cm for male and >80 cm for female were screened for other features of MS. As per the IDF criteria 2005, two of the adult criteria were used for adolescents aged 16 years, while a modified version of these criteria was applied to those aged 10–16 years (use 90th percentile cutoff point for WC). Country/Ethnic group values for WC were included in this criteria.
IDF criteria for MS in children older than 16 years and adult
Central obesity [(WC) >80 cm for women, >90 cm for men].
Plus any two of the following factors:
- Triglyceride (TGL) >150 mg/dl
- High-density lipoprotein (HDL) <40 mg/dl in male, <50 mg/dl in female
- Fasting blood sugar (FBS) >100 mg/dl
- Blood pressure (BP) >130/85 mmHg.
IDF criteria for MS in children aged 10–16 years
Central obesity (WC >90th percentile).
Plus any two or more of the following features:
- FBS >100 mg/dl
- TGL >150 mg/dl
- HDL <40 mg/dl in male, <50 mg/dl in female
- BP >130/85.
A detailed clinical history, which included the duration, drug intake, family history, and personal history (smoking, alcohol, and occupation), was elicited. A complete general, systemic, and dermatological examination were made. Their WC was measured in a horizontal plane, midway between the inferior margin of the ribs and the superior border of the iliac crest and BP was measured. The morphology of the skin lesions, its distribution, and involvement of hair, nail, palms, soles, and mucosa were noted. Laboratory investigations like FBS, fasting TGL, and HDL were done. A total of 113 cases of LP were included in the study. Among them, four clinically doubtful cases were proved histopathologically, and in one case of follicular LP in a 53-year-old female, dermascopy findings supplemented for the diagnosis.
The data were compiled and the statistical analysis was carried out with SPSS 16 and Sigma Stat 3.5 version. One way ANOVA, Chi-square test were used for detection of significance. P<0.05 was considered as significant.
| Results|| |
Out of the total of 113 cases, classical LP (63.7%) was the commonest type followed by hypertrophic LP, eruptive LP, oral LP, linear LP, follicular LP, lichen planus pigmentosus (LPP), and annular LP in the decreasing order of frequency. Majority of the patients were in the fifth decade (41–50 years). Females (62%) were more commonly affected when compared to males (38%) in all age groups. Hypertrophic LP and linear LP were more common in males. In all other variants, female preponderance was seen. Out of 113, 21 cases were found to be associated with MS [Table 1]. In consideration to the confounding variables, all females in our study had no smoking and alcohol habit, and in a total of 43 males, 14 and 7 had history of smoking and alcohol, respectively. As these variables were not equal in distribution, they were not taken into account for the analysis of association between MS and LP [Table 2]. Other confounding variable physical activity was analyzed and found no statistically significant association between cases with MS and physical activity in our study [Table 3].
| Discussion|| |
LP is a chronic inflammatory disease involving skin, mucous membrane, nail, and hair follicle. Th1 cytokines IL-2, 4, 6, 10, and TNF-α involved in the pathogenesis of LP also play a causal role in risk factors of MS including central obesity, dyslipidemia, hypertension, and insulin resistance. These risk factors are the strong predictor of diabetes, cardiovascular diseases, and stroke., Few studies proved the association of oral LP with MS and also with its components, namely, dyslipidemia.,
This was an observational study in which a total of 113 newly diagnosed cases of all variants of LP presented in the age group of 10 and above were included.
Classical LP was the commonest type seen which was consistent with the study conducted by Parihar et al., followed by hypertrophic LP, eruptive LP, oral LP, linear LP, follicular LP, LPP, and annular LP in decreasing order of frequency.
Majority of the patients affected were in the fifth decade (24.8%), whereas in the study conducted by Omal et al., majority of the patients were in third and sixth decade. Females (62%) were predominantly affected when compared to males (38%) similar to the study conducted by Parihar et al.
In 113 patients, 21 (18.6%) cases had MS. In a total of 21 cases of MS, 17 (81%) were females and 4 (19%) were males. Therefore, MS was significantly higher in females compared to males (P<0.001).
Prevalence of increased WC was high among LP patients when compared to other MS criteria similar to the study done by Kurian et al. Regarding distribution of MS cases in different age groups, more number of cases [12 (57.1%)] were found to be in the age group of 41–50. Thus, association of LP with MS in the fifth decade was significantly (P=0.007) high, whereas the study conducted by Prasad et al. showed higher prevalence of MS in the seventh decade.
Among the 21 cases associated with MS, 10 cases were of classical LP, 8 cases were of eruptive type, and the remaining 3 cases were one each of hypertrophic LP, mucosal LP, and LPP.
In a total of 13 cases of eruptive LP, 8 cases were found to be associated with MS. Among them, four belonged to the age group of 41–50 and two were in the age group of 31–40 and 51–60. On comparing other variants, eruptive LP had significant association with MS (P
The confounding variables, smoking and alcohol with its unequal distribution, are not taken into account for the analysis. According to their occupation, physical activity was classified  among cases associated with MS and non-MS in different age groups. There was no statistically significant association between physical activity and MS cases and with variants of LP (P= 0.07 and 0.412, respectively) [Table 3] and [Table 4]. Thus, confounding variables like smoking, alcohol, and physical activity had no significant association with MS cases in our study.
With WC as a mandatory criterion in MS cases, in eruptive LP, increased FBS was frequently found to be associated criterion. There existed statistically significant association between WC and FBS in eruptive LP associated with MS (P =0.032) when compared to cases not associated with MS.
In a case-control study by Baykal et al., prevalence of MS was higher in mucosal LP than without mucosal involvement, and in a study by Krishnamurthy et al., dyslipidemia was significantly high in oral LP patients, whereas in our study in a total of five cases of mucosal LP, only one case in the age group of 61–70 years was found to be associated with MS. Hence, more numbers of oral LP cases are to be studied to find any association.
| Conclusion|| |
Eruptive LP was found to be significantly associated with MS when compared to other variants. Females in the age group of 41–50 were more commonly affected. Physical activity had no significant association with eruptive LP in our study. With central obesity as a common factor, insulin resistance, one of the components of MS, showed significant association in these individuals. Thus, obesity, a pro-inflammatory condition, leads to metabolic changes which may play a part in pathogenesis of eruptive LP. Hence, eruptive LP may be considered as a marker of MS, to be proved with large sample size in each variant and a control group, which are the limitations in our study.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Altman J, Perry HO. The Variations and Course of Lichen Planus. Arch Dermatol 1961;84:179-91.
Pittelkow MR, Daoud MS. Lichen planus. In: Wolff K, Gold-smith LLA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Editors. Fitxpatrick's Dermatology in General Medicine. 7th
ed. New York: McGraw Hill; 2008. P. 244-55.
Palit A, Inamdar AC. Pathogenesis of lichen planus. In: Khopkar U, Valia A, editor. Lichen Planus, 1st
ed. Delhi: Jaypee; 2013. p. 2.
Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008;93:S64-73.
Baykal L, Arıca DA, Yaylı S, Örem A, Bahadır S, Altun E, et al
. Prevalence of metabolic syndrome in patients with mucosal lichen planus: A case–control study. Am J Clin Dermatol 2015;16:439-45.
Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al
. The metabolic syndrome in children and adolescents – An IDF consensus report. Pediatr Diabetes 2007;8:299-306.
Boden, G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 2011;18:139-43.
Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA. Impact of obesity on cardiovascular disease. Med Clin North Am 2011;95:919-37.
Krishnamoorthy B, Suma GN, Mamatha NS, Sowbhagya MB, Garlapati K. Lipid profile and metabolic syndrome status in patients with oral lichen planus, oral lichenoid reaction and healthy individuals attending a dental college in northern India-a descriptive study. J Clin Diagn Res 2014;8:ZC92-5.
Parihar A, Sharma S, Bhattacharya SN, Singh UR. A clinicopathological study of cutaneous lichen planus. J Dermatol Dermatol Surg 2015;19:21-6.
Omal P, Jacob V, Prathap A, Thomas N. Prevalence of oral, skin, and oral and skin lesions of lichen planus in patients visiting a dental school in Southern India. Indian J Dermatol 2012;57:107-9.
] [Full text]
Kurian G, Krishnan S, Shakthi P. A prospective case control study on metabolic syndrome in lichen planus in a tertiary care centre. Int J Res Dermatol 2017;3:427-32.
Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res 2012;3:204-11. [Full text]
Centers for Disease Control and Prevention. General physical activities defined by level of intensity adapted from US Department of Health and Human Services, Promoting Physical Activity: A Guide for Community Action 2005.
[Table 1], [Table 2], [Table 3], [Table 4]
| Article Access Statistics|
| Viewed||144 |
| Printed||2 |
| Emailed||0 |
| PDF Downloaded||9 |
| Comments ||[Add] |